Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Real-world genomic profiling of solid tumors: validation and clinical insights from a Brazilian cohort.

Einstein (Sao Paulo, Brazil)·2026
Same author

Diagnostic performance, molecular analysis, and complications in CT-guided percutaneous biopsies of lung nodules with 20-gauge needles.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia·2026
Same author

A molecular approach to triple-negative breast cancer: targeting the Notch signaling pathway.

Einstein (Sao Paulo, Brazil)·2024
Same author

Real-world genomic profiling of acute myeloid leukemia and the impact of European LeukemiaNet risk stratification 2022 update.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2023
Same author

Molecular profile of patients with myelofibrosis: a 10-year experience.

Einstein (Sao Paulo, Brazil)·2023
Same author

Adaptation to chronic ER stress enforces pancreatic β-cell plasticity.

Nature communications·2022

Related Experiment Video

Updated: May 5, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

12.2K

Mutational signatures in hematological malignancies.

Felipe de Almeida Sartori1,2, João Vitor Paes Pontes2, Paulo Vidal Campregher2,3

  • 1Case Western Reserve University, Cleveland, Ohio, United States.

Einstein (Sao Paulo, Brazil)
|February 19, 2026
PubMed
Summary

Somatic mutations in tumors reveal distinct mutational signatures from various processes. Analyzing these signatures in hematological cancers offers insights into cancer causes and personalized treatment strategies.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

26.1K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

9.3K

Related Experiment Videos

Last Updated: May 5, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

12.2K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

26.1K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

9.3K

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Somatic mutations in human tumors reflect underlying mutational processes, each leaving a unique signature.
  • High-throughput DNA sequencing enables genome-wide assessment of mutation types, driving the development of signature inference methods.
  • Mutational signatures can elucidate cancer etiologies and inform patient treatment, though most research focuses on solid tumors.

Purpose of the Study:

  • To review the history and methodology of mutational signature inference.
  • To address challenges in applying these methods to hematological cancers.
  • To highlight the potential of studying mutational signatures in normal blood cells for understanding cancer development.

Main Methods:

  • Review of existing literature on mutational signature inference.
  • Analysis of challenges specific to hematological cancers.
  • Survey of current research on mutational signatures in blood cancers and normal blood cells.

Main Results:

  • Existing mutational signature inference methods have limited application to hematological cancers.
  • Research on normal blood cells provides a continuum from hematopoiesis to malignancy.
  • Characterizing mutational signatures aids in understanding cancer development.

Conclusions:

  • Mutational signature analysis holds promise for understanding hematological malignancies.
  • Further research is needed to refine methods for blood cancers.
  • Accurate characterization can improve clinical diagnosis, prognosis, and treatment decisions.